192 related articles for article (PubMed ID: 20601920)
1. B7-H1 expression in vestibular schwannomas.
Archibald DJ; Neff BA; Voss SG; Splinter PL; Driscoll CL; Link MJ; Dong H; Kwon ED
Otol Neurotol; 2010 Aug; 31(6):991-7. PubMed ID: 20601920
[TBL] [Abstract][Full Text] [Related]
2. T-cell coregulatory molecule expression in urothelial cell carcinoma: clinicopathologic correlations and association with survival.
Boorjian SA; Sheinin Y; Crispen PL; Farmer SA; Lohse CM; Kuntz SM; Leibovich BC; Kwon ED; Frank I
Clin Cancer Res; 2008 Aug; 14(15):4800-8. PubMed ID: 18676751
[TBL] [Abstract][Full Text] [Related]
3. cDNA microarray analysis of vestibular schwannomas.
Welling DB; Lasak JM; Akhmametyeva E; Ghaheri B; Chang LS
Otol Neurotol; 2002 Sep; 23(5):736-48. PubMed ID: 12218628
[TBL] [Abstract][Full Text] [Related]
4. Deregulated genes in sporadic vestibular schwannomas.
Cayé-Thomasen P; Borup R; Stangerup SE; Thomsen J; Nielsen FC
Otol Neurotol; 2010 Feb; 31(2):256-66. PubMed ID: 19816230
[TBL] [Abstract][Full Text] [Related]
5. Human vestibular schwannoma growth in the nude mouse: evaluation of a modified subcutaneous implantation model.
Stidham KR; Roberson JB
Am J Otol; 1997 Sep; 18(5):622-6. PubMed ID: 9303159
[TBL] [Abstract][Full Text] [Related]
6. Implications of B7-H1 expression in clear cell carcinoma of the kidney for prognostication and therapy.
Thompson RH; Dong H; Kwon ED
Clin Cancer Res; 2007 Jan; 13(2 Pt 2):709s-715s. PubMed ID: 17255298
[TBL] [Abstract][Full Text] [Related]
7. Expression of vascular endothelial growth factor and basic fibroblast growth factor in sporadic vestibular schwannomas correlates to growth characteristics.
Koutsimpelas D; Stripf T; Heinrich UR; Mann WJ; Brieger J
Otol Neurotol; 2007 Dec; 28(8):1094-9. PubMed ID: 17721409
[TBL] [Abstract][Full Text] [Related]
8. Radiosurgery for intracanalicular vestibular schwannomas.
Niranjan A; Mathieu D; Kondziolka D; Flickinger JC; Lunsford LD
Prog Neurol Surg; 2008; 21():192-199. PubMed ID: 18810219
[TBL] [Abstract][Full Text] [Related]
9. FOXP3+ Tregs and B7-H1+/PD-1+ T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: Implication for immunotherapy.
Ghebeh H; Barhoush E; Tulbah A; Elkum N; Al-Tweigeri T; Dermime S
BMC Cancer; 2008 Feb; 8():57. PubMed ID: 18294387
[TBL] [Abstract][Full Text] [Related]
10. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Hearing Preservation Outcomes in Patients With Sporadic Vestibular Schwannomas.
Carlson ML; Vivas EX; McCracken DJ; Sweeney AD; Neff BA; Shepard NT; Olson JJ
Neurosurgery; 2018 Feb; 82(2):E35-E39. PubMed ID: 29309683
[TBL] [Abstract][Full Text] [Related]
11. Conservative management versus stereotactic radiation for vestibular schwannomas: a meta-analysis of patients with more than 5 years' follow-up.
Maniakas A; Saliba I
Otol Neurotol; 2012 Feb; 33(2):230-8. PubMed ID: 22222572
[TBL] [Abstract][Full Text] [Related]
12. Predictors of vestibular schwannoma growth and clinical implications.
Agrawal Y; Clark JH; Limb CJ; Niparko JK; Francis HW
Otol Neurotol; 2010 Jul; 31(5):807-12. PubMed ID: 20502379
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-21 overexpression contributes to vestibular schwannoma cell proliferation and survival.
Cioffi JA; Yue WY; Mendolia-Loffredo S; Hansen KR; Wackym PA; Hansen MR
Otol Neurotol; 2010 Dec; 31(9):1455-62. PubMed ID: 20856158
[TBL] [Abstract][Full Text] [Related]
14. A systematic review and meta-analysis of stereotactic radiosurgery as a primary treatment in fast-growing vestibular schwannomas.
Shah F; Hamilton LOW; Yiannakis CP; Slim MAM; Kontorinis G
J Laryngol Otol; 2023 Nov; 137(11):1193-1199. PubMed ID: 37194631
[TBL] [Abstract][Full Text] [Related]
15. Tumor-associated macrophages are related to volumetric growth of vestibular schwannomas.
de Vries M; Briaire-de Bruijn I; Malessy MJ; de Bruïne SF; van der Mey AG; Hogendoorn PC
Otol Neurotol; 2013 Feb; 34(2):347-52. PubMed ID: 23295727
[TBL] [Abstract][Full Text] [Related]
16. T-cell co-regulatory molecule expression in renal angiomyolipoma and pulmonary lymphangioleiomyomatosis.
Boorjian SA; Sheinin Y; Crispen PL; Lohse CM; Leibovich BC; Kwon ED
Urology; 2009 Dec; 74(6):1359-64. PubMed ID: 19501877
[TBL] [Abstract][Full Text] [Related]
17. Reporting success rates in the treatment of vestibular schwannomas: are we accounting for the natural history?
Miller T; Lau T; Vasan R; Danner C; Youssef AS; van Loveren H; Agazzi S
J Clin Neurosci; 2014 Jun; 21(6):914-8. PubMed ID: 24656737
[TBL] [Abstract][Full Text] [Related]
18. Cyclin D(1) and D(3) expression in vestibular schwannomas.
Neff BA; Oberstien E; Lorenz M; Chaudhury AR; Welling DB; Chang LS
Laryngoscope; 2006 Mar; 116(3):423-6. PubMed ID: 16540902
[TBL] [Abstract][Full Text] [Related]
19. Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1/programmed death-1 interactions.
Wu K; Kryczek I; Chen L; Zou W; Welling TH
Cancer Res; 2009 Oct; 69(20):8067-75. PubMed ID: 19826049
[TBL] [Abstract][Full Text] [Related]
20. Hormone receptors in vestibular schwannomas.
Carroll RS; Zhang JP; Black PM
Acta Neurochir (Wien); 1997; 139(3):188-92; discussion 193. PubMed ID: 9143583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
